160 related articles for article (PubMed ID: 21072226)
1. Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection.
Carrera-Silva EA; Guiñazu N; Pellegrini A; Cano RC; Arocena A; Aoki MP; Gea S
PLoS Negl Trop Dis; 2010 Nov; 4(11):e863. PubMed ID: 21072226
[TBL] [Abstract][Full Text] [Related]
2. TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB/c and C57BL/6 mice during Trypanosoma cruzi acute infection.
Carrera-Silva EA; Cano RC; Guiñazú N; Aoki MP; Pellegrini A; Gea S
Mol Immunol; 2008 Aug; 45(13):3580-8. PubMed ID: 18565585
[TBL] [Abstract][Full Text] [Related]
3. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
[TBL] [Abstract][Full Text] [Related]
4. MyD88 Adapter-like (Mal)/TIRAP Is Required for Cytokine Production by Splenic Ly6CloTLR2hi but Not by Ly6ChiTLR2hi Monocytes during Trypanosoma cruzi Infection.
Gravina HD; Goes AM; Murta SM; Ropert C
J Biol Chem; 2016 Nov; 291(45):23832-23841. PubMed ID: 27646001
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection.
Bafica A; Santiago HC; Goldszmid R; Ropert C; Gazzinelli RT; Sher A
J Immunol; 2006 Sep; 177(6):3515-9. PubMed ID: 16951309
[TBL] [Abstract][Full Text] [Related]
6. Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi.
Gravina HD; Antonelli L; Gazzinelli RT; Ropert C
PLoS One; 2013; 8(5):e63100. PubMed ID: 23650544
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection.
Arocena AR; Onofrio LI; Pellegrini AV; Carrera Silva AE; Paroli A; Cano RC; Aoki MP; Gea S
Eur J Immunol; 2014 Jan; 44(1):184-94. PubMed ID: 24166778
[TBL] [Abstract][Full Text] [Related]
8. An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of
Mateus J; Guerrero P; Lasso P; Cuervo C; González JM; Puerta CJ; Cuéllar A
Front Immunol; 2019; 10():918. PubMed ID: 31105709
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi.
Ropert C; Gazzinelli RT
J Endotoxin Res; 2004; 10(6):425-30. PubMed ID: 15588426
[TBL] [Abstract][Full Text] [Related]
10. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection.
Ponce NE; Cano RC; Carrera-Silva EA; Lima AP; Gea S; Aoki MP
Med Microbiol Immunol; 2012 May; 201(2):145-55. PubMed ID: 21984337
[TBL] [Abstract][Full Text] [Related]
12. Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.
Murray HW; Zhang Y; Zhang Y; Raman VS; Reed SG; Ma X
Infect Immun; 2013 Jul; 81(7):2318-26. PubMed ID: 23589575
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: acute infection affects expression of alpha-2-macroglobulin and A2MR/LRP receptor differently in C3H and C57BL/6 mice.
Soeiro Mde N; Paiva MM; Waghabi MC; Meirelles Mde N; Lorent K; Henriques-Pons A; Coutinho CM; Van Leuven F; Araújo-Jorge TC
Exp Parasitol; 2000 Oct; 96(2):97-107. PubMed ID: 11052868
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.
Onofrio LI; Arocena AR; Paroli AF; Cabalén ME; Andrada MC; Cano RC; Gea S
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003464. PubMed ID: 25668433
[TBL] [Abstract][Full Text] [Related]
15. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi.
Oliveira AC; Peixoto JR; de Arruda LB; Campos MA; Gazzinelli RT; Golenbock DT; Akira S; Previato JO; Mendonça-Previato L; Nobrega A; Bellio M
J Immunol; 2004 Nov; 173(9):5688-96. PubMed ID: 15494520
[TBL] [Abstract][Full Text] [Related]
16. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
Dhiman M; Garg NJ
PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.
Zhan R; Han Q; Zhang C; Tian Z; Zhang J
Infect Immun; 2015 Apr; 83(4):1641-9. PubMed ID: 25667264
[TBL] [Abstract][Full Text] [Related]
18. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
19. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression.
Guiñazú N; Pellegrini A; Carrera-Silva EA; Aoki MP; Cabanillas AM; Gìronés N; Fresno M; Cano R; Gea S
Int J Parasitol; 2007 Sep; 37(11):1243-54. PubMed ID: 17512528
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Target of Rapamycin Inhibition in
Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
Front Immunol; 2018; 9():313. PubMed ID: 29515594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
